CytomX

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CytomX and other ETFs, options, and stocks.

About CTMX

CytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline includes immunotherapies, probody drug conjugates, T cell engaging bispecifics, and other multiple programs. 

CEO
Sean A. McCarthy
CEOSean A. McCarthy
Employees
174
Employees174
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2010
Founded2010
Employees
174
Employees174

CTMX Key Statistics

Market cap
96.62M
Market cap96.62M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
460.70K
Average volume460.70K
High today
$1.49
High today$1.49
Low today
$1.42
Low today$1.42
Open price
$1.49
Open price$1.49
Volume
266.75K
Volume266.75K
52 Week high
$7.53
52 Week high$7.53
52 Week low
$1.19
52 Week low$1.19

Analyst ratings

60%

of 10 ratings
Buy
40%
Hold
60%
Sell
0%

CTMX Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, After Hours
ActualExpected Nov 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.